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Abstract
DOC-2/DAB2 interactive protein (DAB2IP) is a novel identified tumor suppressor gene that inhibits cell growth and facilitates
cell apoptosis. One genetic variant in DAB2IP gene was reported to be associated with an increased risk of aggressive
prostate cancer recently. Since DAB2IP involves in the development of lung cancer and low expression of DAB2IP are
observed in lung cancer, we hypothesized that the variations in DAB2IP gene can increase the genetic susceptibility to lung
cancer. In a case-control study of 1056 lung cancer cases and 1056 sex and age frequency-matched cancer-free controls, we
investigated the association between two common polymorphisms in DAB2IP gene (21420T.G, rs7042542; 97906C.A,
rs1571801) and the risk of lung cancer. We found that compared with the 97906CC genotypes, carriers of variant genotypes
(97906AC+AA) had a significant increased risk of lung cancer (adjusted odds ratio [OR]=1.33, 95%CI=1.04–1.70, P=0.023)
and the number of variant (risk) allele worked in a dose-response manner (Ptrend=0.0158). Further stratification analysis
showed that the risk association was more pronounced in subjects aged less than 60 years old, males, non-smokers, non-
drinkers, overweight groups and in those with family cancer history in first or second-degree relatives, and the 97906A
interacted with overweight on lung cancer risk. We further found the number of risk alleles (97906A allele) were negatively
correlated with early diagnosis age of lung cancer in male patients (P=0.003). However, no significant association was
observed on the 21420T.G polymorphism. Our data suggested that the 97906A variant genotypes are associated with the
increased risk and early onset of lung cancer, particularly in males.
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Introduction
Lung cancer is the most common type of cancer and the
number one cause of death among tumor types in the world [1]. In
the United States, it was estimated that there would be 222,520
new lung cancer incidences and 157,300 lung cancer deaths in
2010 [1]. Data from the national death survey and cancer
registration of China mainland also showed that lung cancer was
the leading cause of death in most of cities in China [2]. In
Guangzhou, the incidence rate of lung cancer was 61.18/10
5 in
males, and 32.56/10
5 in females in 2004, accordingly, with a
death rate of 59.37/10
5 in males, and 27.82/10
5 in females [2]. All
these indicated that the burdens of lung cancer are serious all over
the world, especially in males.
Epidemiologic studies have showed that the most etiological
factors of lung cancer are from environment, including cigarette
smoking, occupational exposure to polycyclic aromatic hydrocar-
bons, asbestos, metals, and welding fumes, air pollution, and
malnutrition or diets [3]. However, only a small portion of
individuals who expose to hazardous environmental factors
developed lung cancer disease, which suggests that factors other
than environment, such as the host (e.g., chronic lung diseases) or
genetic factors (e.g., gene variation) may predispose individuals to
develop lung cancer [4]. Recently, a meta-analysis including
results from 41 studies reported that the lung cancer family history
was a risk factor of lung cancer [5]. These demonstrated that the
genetic factor plays a role in the development of human lung
cancer.
DAB2IP, the coding gene of DOC-2/DAB2IP protein, also
known as apoptosis signal- regulating kinase 1–interacting protein-
1 (AIP1), is a novel member of the RAS GTPase- activating gene
family. DAB2IP, not only directly activates TNF- induced ASK1-
JNK cell apoptotic signaling and inhibits TNF- induced IKK- NF-
kB cell growth signaling [6–8], it also suppresses the phosphati-
dylinositol 3-kinase (PI3K)-Akt pathway and thus leads to cell
apoptosis [9] and negatively regulate RAS-mediated cell survival
signal via its interaction with DAB2 [10]. Moreover, study also
revealed a function of DAB2IP in modulating epithelial-to-
mesenchymal transition and cancer metastasis [11]. Due to the
aberrant methylation in the DAB2IP promoter region, low
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including lung cancer, and increased level of DAB2IP can suppress
cancer growth [12–17]. DAB2IP knockout mice showed that
deficiency of DAB2IP protein can strongly augment epithelial cell
migration and inflammatory angiogenesis [18]. All the data
suggests that DAB2IP may function as a tumor suppressor gene.
DAB2IP gene locates at chromosome 9q33.1–33.3. It is high
polymorphic, 1457 polymorphisms and two common different
transcripts have been reported in this gene. Recently, one study
reported that a genetic polymorphism (rs1571801) in intron 1 of
DAB2IP gene was significantly associated with increased risk of
aggressive prostate cancer both in African American and
European population [19]. Because most of the lung cancer
patients are males and DAB2IP deficient was also founded in lung
cancer [15], it is likely that the genetic variation in DAB2IP gene
may contribute to increase the risk of lung cancer as it did in
prostate cancer. Variations in the promoter of this gene may affect
gene’s functions. Taken these together, we hypothesized that the
genetic variations in DAB2IP gene and their possible interactions
with environmental factors are associated with the risk of lung
cancer.
In this hospital-based case-control study including 1056 lung
cancer patients and 1056 sex and age frequency-matched genetic
unrelated cancer-free controls, we genotyped two common
polymorphisms in DAB2IP gene (21420T.G, rs7042542, in
promoter region; 97906C.A, rs1571801, in intron 1) and
investigated their association with the risk of lung cancer.
Results
Subjects’ demographics
The distributions of demographic variables and risk factors of
the 1056 cases and the 1056 cancer-free controls have been
described elsewhere [20] and these variables were further adjusted
for the multivariate logistic regression model to control possible
confounding of the main effects of the studied SNP and used in the
later stratification and gene- environment interaction analysis. In
addition, of the 1056 cases, there were 683(64.7%) cases of
cantoneses, 90(8.5%) teocheweses, 198(18.8%) hakkases and
85(8.0%) subjects from other provinces. of the 1056 controls,
there were 700(66.2%) cantoneses, 81(7.7%) teocheweses,
195(18.5%) hakkases and 80(7.6%) subjects from other provinces.
The difference in distributions of sub-nation between cases and
controls were not statistically significant (P=0.8538) and this was
used in the later and gene-environment interaction stratification
analysis (Table 1).
The distributions of DAB2IP genotypes and the risk of
lung cancer
The distributions of the two SNPs genotypes among the controls
and cases, and the adjusted odds ratios associated with lung cancer
are summarized in Table 2. Both genotype frequencies in control
population were in agreement with those predicted under Hardy-
Weinberg equilibrium (P=0.454 for 21420T.G; P=0.113 for
97906C.A). Genetic linkage disequilibrium between the
21420T.G locus and 97906C.A locus did not occur as the
LD analysis in controls shown (D9=0.015 and r
2=0.001),
suggesting each may have an independent effect on risk of lung
cancer.
As shown in Table 2, Allele frequency of 97906C.A SNP was
shown significant differences between the cases and controls
(P=0.0381). Multivariate logistic regression analysis showed that
after adjusting for confounding factors, compared with CC
genotypes, CA had a significantly increased risk of lung cancer
(adjusted odds ratios [OR]=1.31; 95% CI=1.01–1.68;
P=0.0436), the AA homozygote had a non-significantly increased
risk of lung cancer (adjusted OR=1.90; 95%CI=0.80–4.53;
P=0.1438) because of its rare frequency, but there was a
significant trend for an allele dose effect on risk of lung cancer
(Ptrend=0.0158). Under the co-dominant model of inheritance, the
carriers of A allele (i.e., CA/AA genotypes) had a 0.33-fold
increased risk of lung cancer (95%CI =1.04–1.70; P=0.023).
However, for the 21420T.G SNP, the genotype and allele
frequencies did not differ significantly between the cases and the
controls (P=0.5263 and 0.4549, respectively). Consistently, there
was no significant association between this SNP and risk of lung
cancer.
Stratification analysis of DAB2IP 97906C.A genotypes
and risk of lung cancer
We further evaluated the associations of the 97906CA/AA
variant genotypes with lung cancer risk stratified by selected
variables. As shown in Table 3, compared with the common wild-
type homozygous genotype, the detrimental genotypes 97906CA/
AA were more pronounced in males (adjust OR=1.42, 95%
Table 1. Frequency distributions of selected variables in LC
patients and cancer-free controls.
Variables Patients (n=1056) Controls (n=1056) P
a
N % N %
Age (years) 0.9306
#60 536 50.8 534 50.6
.60 520 49.2 522 49.4
Sex 1.000
Male 746 70.6 746 70.6
Female 310 29.4 310 29.4
Smoking status 0.0283
Current 394 37.3 366 34.7
Former 207 19.6 176 16.7
Never 455 43.1 514 48.6
Alcohol drinking 0.0429
Current 165 15.6 186 17.6
Former 64 6.1 41 3.9
Never 827 78.3 829 78.5
Family history of
cancer
0.9417
Yes 104 9.9 103 9.8
No 952 90.1 953 90.2
BMI(kg/m
2) ,.0001
,18 134 12.7 51 4.8
18–25 820 77.6 702 66.5
.25 102 9.7 303 28.7
Sub-ethic 0.8538
Cantonese 683 64.7% 700 66.2%
Teochewese 90 8.5% 81 7.7%
Hakkas 198 18.8% 195 18.5%
Other provinces 85 8.0% 80 7.6%
aP values for a two-sided x
2 test.
doi:10.1371/journal.pone.0026944.t001
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CI=1.06–2.14), in non-smokers(adjust OR=1.43, 95% CI=
1.00–2.10), in nondrinkers (adjust OR=1.45, 95% CI=1.10–
1.92), in overweight groups (adjust OR=2.33, 95% CI=1.30–
4.16) and in those with family cancer history in first or second-
degree relatives(adjust OR=2.55, 95% CI=1.04–6.25). Whereas,
no significant association between the 21420T.G polymorphism
and the risk of lung cancer was found in any of the subgroups (data
not shown).
Furthermore, we assessed possible interactions (or effect
modifications) between the polymorphism and age, sex, smoking,
drinking, family history of cancer, and BMI groups on cancer risk.
While fitting multiplicative models, we only found that the 97906A
variant genotypes interacted with BMI on increasing cancer risk
(interaction test P=0.0348). We further analyzed the possible
interactions with the Multifactor Dimensionality Reduction
(MDR) software, and found that there were interactions of the
97906A variant genotypes, BMI and smoking on increasing cancer
risk (interaction test P=0.0003). These results suggest a possibility
of interaction between 97906A variant genotypes and overweight
on lung cancer risk.
Age at onset of lung cancer and variants of DAB2IP
Because an early age at onset of cancer is a feature of genetic
susceptibility to the disease, we analyzed the relationship between
age at onset of lung cancer patients and the genotypes of DAB2IP,
A Pearson correlation analysis showed that age at onset decreased
significantly as the number of risk alleles increased in males
(r=20.11, P=0.0026), but not in females (r=20.06, P=0.2923).
We further assigned those 746 male patients to one of three groups
on the basis of the number of risk alleles, and found that the age at
onset (mean 6 SD) was 61.1611.7 years in 610 patients with zero
risk allele (i.e., CC genotypes), it was significantly lower in 124
patients with one risk allele (CA genotypes) (58.8611.2); and it was
further decreased in 12 patients with two risk alleles (AA
genotypes) (55.469.5). The carriers of 97906CA or AA genotypes
were 2.3 years or 5.7 years younger than that of CC genotypes.
(ANOVA test P=0.0386) (Fig. 1). We further performed Cox
regression analysis with and without adjustments for sex, age,
smoke status, drink status and BMI, and found that the genetic
variant 97906A (97906CA and AA) of DAB2IP was an
independent factor for the early onset of lung cancer patients
(P=0.033, Pad=0.031).
Association between the 97906C.A genotype and
DAB2IP mRNA levels
As shown in Figure 2A, the mRNA levels of DAB2IP in 32 lung
cancer tissues were significantly lower than their adjacent normal
tissues (P,0.001). However, the differences of DAB2IP mRNA
expression among 97906C.A genotypes were not significant in
neither tumor tissues (P=0.188) nor normal tissues (P=0.165), as
shown in Figure 2B and 2C. It suggested that the SNP
97906C.A may have no significant impact on this gene’s
expression.
Detection of DAB2IP/MLL fusion gene
In genotyping analysis of 97906C.A genotypes in those 82 lung
cancer tissues and their adjacent normal tissues, we found that of
cancer tissues 19 cases were carriers of CA, 2 cases were AA, of the
adjacent normal tissues 17 cases were carriers of CA and one case
was AA. We amplified the fragment of DAB2IP/MLL fusion gene
with PCR method as von Bergh AR described for all of those 82
lung cancer tissues and their adjacent normal tissues. However, we
failed to detect AB2IP/MLL fusion gene.
Table 2. Distribution of genotypes in DAB2IP and results of logistic regression analysis for associations with risk of LC.
Genotypes Patients Controls
a
P
b
Crude
OR (95% CI)
Adjusted
OR (95% CI)
c
n (%) n (%)
Total no. of subjects 1056 1056
Total no. of alleles 2122 2122
rs7042542(21420T.G) 0.5263
TT 830(78.6) 847(80.2) 1.00 (ref.) 1.00 (ref.)
GT 219(20.7) 200(18.9) 1.12(0.90–1.38) 1.09(0.87–1.37)
GG 7(0.7) 9(0.9) 0.80(0.30–2.14) 0.81(0.29–2.22)
Trend test P value 0.4459 0.5783
GT+GG 224(21.4) 209(19.8) 1.10(0.89–1.36) 1.08(0.87–1.35)
G allele 0.110 0.103 0.4549
rs1571801(97906C.A) 0.0381
CC 870 (82.4) 912 (86.4) 1.00 (ref.) 1.00 (ref.)
CA 172 (16.3) 135 (12.8) 1.34 (1.05–1.70) 1.31 (1.01–1.68)
AA 14 (1.3) 9 (0.8) 1.63 (0.70–3.79) 1.90 (0.80–4.53)
Trend test P value 0.0111 0.0158
CA+AA 186 (17.6) 144 (13.6) 1.35(1.07–1.72) 1.33 (1.04–1.70)
A allele 0.095 0.072 0.0090
aThe observed genotype frequencies among the control subjects were in agreement with the Hardy-Weinberg equilibrium (p
2+2pq+q
2=1)(x
2=2.51, P=0.113 for
97906C.A; x
2=0.56, P=0.454 for 21420T.G).
bAdjusted in a logistic regression model that included age, sex, smoking status, alcohol use, BMI, family history of cancer.
cA two-sided x
2 tests for differences in distribution of genotype frequencies between cases and controls.
doi:10.1371/journal.pone.0026944.t002
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In this lung cancer case–control study in a southern Chinese
population, we investigated association between two common
variants of DAB2IP and the risk of lung cancer with a relatively
large sample size of 1056 lung cancer patients and 1056 cancer-
free controls. Significant association was observed between the
97906C.A polymorphism and lung cancer risk. The 97906A
variant genotypes were found to be associated with increased
risk, especially in the subgroups of subjects younger than 60
years, males, never smokers, never drinkers, overweighter or
obesities, and those with family cancer history. Furthermore, the
increased number of risk alleles was associated with more early
age at onset of lung cancer. However, for the polymorphism
21420T.G, no evidence was found for any association between
Table 3. Stratification analysis of the DAB2IP 97906C.A genotypes by selected variables in LC patients and controls.
Patients (n=1056) Controls (n=1056)
Crude OR
(95% CI)
Adjusted OR
(95% CI)
a
CC
n (%)
CA+AA
n (%)
CC
n (%)
CA+AA
n (%) CA+AA vs CC CA+AA vs CC Pinteraction
b
Age (years)
#60 442 (82.5) 94(17.5) 467(87.5) 67(12.5) 1.48 (1.06–2.08) 1.51(1.06–2.14) 0.4357
.60 428 (82.3) 92(17.7) 445 (85.2) 77(14.8) 1.24 (0.90–1.73) 1.16(0.82–1.65)
Sex
Male 612 (82.0) 134 (18.0) 642 (86.1) 104 (13.9) 1.35 (1.02–1.79) 1.42 (1.06–1.89) 0.4145
Female 258 (83.2) 52 (16.8) 270 (87.1) 40 (12.9) 1.36 (0.87–2.13) 1.12 (0.70–1.80)
Smoking status
Never 377(82.9) 78(17.1) 456(88.7) 58(11.3) 1.63(1.13–2.35) 1.43(1.11–2.10) 0.9460
Ever 493(82.0) 108(18.0) 456(84.1) 86(15.9) 1.16(0.85–1.59) 1.26(0.91–1.75)
Drinking status
Never 682(82.5) 145(17.5) 723(87.2) 106(12.8) 1.45(1.11–1.90) 1.45(1.10–1.92) 0.4018
Ever 188(82.1) 41(17.9) 189(83.3) 38(16.7) 1.09(0.67–1.76) 1.03(0.62–1.74)
BMI(kg/m
2)
,18 108(80.6) 26(19.4) 40(78.4) 11(21.6) 0.88(0.40–1.93) 0.79(0.34–1.83) 0.0348
18–25 685(83.5) 135(16.5) 607(86.5) 95(13.5) 1.26(0.95–1.67) 1.25(0.94–1.66)
.25 77(75.5) 25(24.5) 265(87.5) 38(12.5) 2.26(1.29–3.99) 2.33(1.30–4.16)
Family history of cancer
YES 84(80.8) 20(19.2) 94(91.3) 9(8.7) 2.49(1.07–5.76) 2.55(1.04–6.25) 0.1371
NO 786(82.6) 166(17.4) 818(85.8) 135(14.2) 1.28(1.00–1.64) 1.26(0.98–1.64)
Sub–ethic 0.6660
c
Cantonese 569(83.3) 114(16.7) 603(86.1) 97(13.9) 1.34(0.64–2.82) 1.35(0.61–3.09)
Teochewese 69(76.7) 21(23.3) 66(81.5) 15(18.5) 1.53(0.87–2.68) 1.70(0.94–3.09)
Hakkas 163(82.3) 35(17.7) 171(87.7) 24(12.3) 1.25(0.93–1.67) 1.24(0.91–1.69)
Other provinces 69(81.2) 16(18.8) 72(90.0) 8(10.0) 2.09(0.84–5.19) 2.05(0.78–5.42)
Histological types
Adenocarcinoma 303(82.1) 66(17.9) 912(86.4) 144(13.6) 1.38(1.01–1.90) 1.26(0.79–1.89) 0.5680
c
Squamous cell carcinoma 312(81.2) 72(18.8) 1.46(1.07–1.99) 1.11(0.72–1.71)
Large cell carcinoma 37(86.0) 6(14.0) 1.03(0.43–2.48) 1.39(0.46–4.33)
Small cell lung cancer 107(83.6) 21(16.4) 1.24(0.75–2.05) 0.72(0.32–1.61)
Other carcinomas
c 111(84.1) 21(15.9) 1.20(0.73–1.97) 0.69(0.32–1.50)
aORs were adjusted for age, sex, smoking status, and alcohol use, BMI, family history of cancer in a logistic regression models.
bP value of a test the multiplicative interaction between 97906C.A and selected variables on cancer risk were calculated using standard unconditional logistic
regression models.
cP value of the test for homogeneity between stratum-related ORs for DAB2IP (97906CA+AA versus CC genotypes).
doi:10.1371/journal.pone.0026944.t003
Figure 1. Age at onset of lung cancer and variants of DAB2IP
gene.
doi:10.1371/journal.pone.0026944.g001
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is the first genotype association study of DAB2IP SNPs and lung
cancer risk.
One study found the intron1 genetic variant 97906A in DAB2IP
was associated with an increased risk of aggressive prostate cancer
[19]. Because of the critical role of DAB2IP in the etiology of lung
cancer, here we found that the 97906C.A SNP was also
associated with an increased risk of lung cancer in males; it
suggests that the 97906A variants may play an important role in
etiologic of lung cancer. We had performed bioinformatics’
analysis with VISTA tools (http://genome.lbl.gov/vista/index.
shtml) by comparing the genomic structures of DAB2IP gene
among human (GeneID: 153090) and mouse (GeneID: 69601), rat
(GeneID: 192126), dog (GeneID: 491356), cow(GeneID: 541268),
we found that the 97906C.A locus locates in evolutionarily
conserved regions (ECRs) which do not changed through
evolution and served as functional cis-acting elements [21]. We
further analyzed the possible genetically statistical similar SNPs to
97906C.A in a 5 Mb region on chromosome 9 via the HapMap
SNP database (release #36, http://www.hapmap.org/, November
9, 2009) genotyped in the CHB trios with the ssSNPer web
interface (http://gump.qimr.edu.au/general/daleN/ssSNPer/). In
a region from 123228424 bp upstream to 123728423 bp down-
stream of 97906C.A, we also found one intron 1 polymorphisms
rs1984038 which was 3184 bp upstream of 97906C.A was in
completely LD (D9=1.00, r
2=1.00) with 97906C.A [22], and it
was also belong to the ECRs. However, we neither found any
significant effect of 97906C.A SNP on the mRNA expressions of
DAB2IP gene in lung cancer tissues and their adjacent normal
tissues; and we failed to detect the possible impact of the SNP on
DAB2IP/MLLfusiongene incancertissues.Takingtheseevidences
together, it demonstrated that 97906C.A is a conserved genetic
marker.
In the stratification analysis, we found that the variant
genotypes (97906CA+97906AA) were more pronounced in male,
younger, never smokers, nondrinkers, overweight groups and
those with family history of cancer. Rigorous environmental
factors such as smoking are risk of lung cancer and gene-
environment interaction is well known involved in the etiology of
lung cancer [23], but here we found that the 97906A variant may
influence the development of lung cancer mostly due to
autochthonous inherited effect. As shown, 97906C.A is more
significant in young individuals, in nonsmokers and in nondrink-
ers. Constantly those with family history of cancer in any first- or
second - degree relatives were more tend to develop lung cancer
due to the genetic background high 97906A frequency. In
addition, we observed consistent evidence for a statistically
significant interaction between the 97906A and overweight. We
supposed androgens may act as an intermediary for the close
correlation between androgens and obesity [24] and androgens,
function on the expression of DAB2IP by suppressing EZH2
expression [25]. Further studies are needed to reveal the
mechanism as accumulated studies have verified that overweight
increases the risk of human cancer, including lung cancer [26].
Interestingly, we also found that the 97906A variant genotypes
were associated with an early onset age of lung cancer in male
patients in an allele dose-effect manner. DAB2IP may relate to the
pathogenesis of lung cancer as study have shown that in prostate
cancer DAB2IP influenced the repair effectiveness of DNA
double-strand breaks induced by medical exposure to ionizing
radiation which is a risk factor of lung cancer [27]. Thus, our
findings demonstrated the 97906C.A polymorphism may be a
conserved genetic marker to predict the risk of lung cancer and
further early onset of lung cancer in males.
Since the present study was a hospital-based case-control study,
restricted to Chinese Han population, it may have some
Figure 2. Association of the 97906C.A genotype and DAB2IP expressions. A, Relative mRNA levels of the DAB2IP expressions in lung cancer
tissues compared to their adjacent normal lung tissues; B, Relative mRNA level of the DAB2IP expression by the 97906C.A genotype in lung cancer
tissues. C, Relative mRNA level of the DAB2IP expression by the 97906C.A genotype in normal tissues. No significant association was observed
between the 97906C.A genotype and DAB2IP mRNA levels neither in cancer tissues nor in normal tissues Columns, mean from three independent
experiments; bars, SD; and Student’s t test was used to test the differences in the expression levels of different constructs.
doi:10.1371/journal.pone.0026944.g002
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21420G, 97906A alleles were 0.103, 0.072, respectively) in the
control subjects of our study were similar to those reported for
Chinese population including in HapMap database (i.e., 21420G,
97906A alleles were 0.114, 0.067, respectively). Moreover, the
genotype frequencies among controls could fit the Hardy–
Weinberg law also suggested the randomness of subject selection.
Von Bergh AR et al. reported that the exon 2 of DAB2IP gene was
fused with MLL gene in an acute myeloid leukemia patient.
However, we failed to observe the DAB2IP/MLL fusion gene in 82
cases of lung cancer tissues and their adjacent normal tissues,
let alone the possible effect of 97906C.A polymorphism on
DAB2IP/MLL fusion gene. Due to the technological limitations,
we did not yet perform any other functional assay to identify
whether 97906C.A locus is in an intronic enhancer or a splicing-
related site. In this association study, we achieved an 80.2% study
power to detect crude OR of 1.35 for the 97906CA+AA genotypes
(which occurred at a frequency of 13.6% in the controls) compared
with the 97906CC genotype. Therefore, it appears to be that the
97906CA+AA genotypes associated with an increased risk of lung
cancer is unlikely to have been obtained by chance.
In conclusion, in this hospital-based case-control study of lung
cancer, we found that the 97906A genetic variants of DAB2IP gene
was associated with early onset age and an increased risk of lung
cancer in males, especially in the subgroups of subjects younger
than 60 years, male, never drinkers, obesities, and those with
family cancer history. To the best of our knowledge, this is the first
study of 97906A genetic variants in DAB2IP gene and lung cancer
susceptibility. Larger, preferably population-based case-control
studies, as well as well-designed mechanistic studies, are warranted
to validate our findings.
Materials and Methods
Study subjects and sample collection
Study subjects of 1056 lung cancer patients and 1056 cancer-
free controls were recruited as previously described [20]. Briefly,
all histopathologically confirmed patients with primary lung
cancer were consecutively recruited at the urban hospitals and
at the suburb of Guangzhou city from March 2007 to March
2009. Those with second lung tumors, or primary tumors upper
tracheal bifurcation were excluded. 1056 cancer-free controls that
were frequency-matched to the cases on age (61 years) and sex
were selected randomly from about 10,000 individuals who
participated in the healthy checkup programs in the community
health stations conducted in Guangzhou City. All subjects were
genetically-unrelated ethnic Han Chinese and were from
Guangzhou City and surrounding regions in Southern China.
None had blood transfusions in last 6 months. A simple
questionnaire was used to collect data on demographic charac-
teristics, including smoking status, alcohol use and other factors
including sex, age, BMI with signed consent form both in cases
and controls. The information of the sub-ethnic (i.e., Cantonese,
Teochewese, Hakkas, and Han ethnic from other provinces
outside Guangdong) was also collected during interviews. All
participants recruited in our study had signed a consent form
before the questionnaire interview and our study was approved by
the Institutional Review Boards of Guangzhou Medical Univer-
sity.
SNP selection
We used the TSSW program (http://www.softberry.ru/berry.
phtml) to predict promoter region and found that the 4000 bp 59-
upstream region of DAB2IP gene are potential promoter region.
Based on the HapMap database (HapMap Data Rel 27 PhaseII
+III, Feb 09, on NCBI B36 assembly, dbSNP b126), we found that
there were nine common SNPs (i.e., with minor allele frequency
$5%) within the promoter region of DAB2IP gene in Chinese Han
Beijing population. We further selected the tagSNPs based on
the pair-wise LD analysis (r
2 threshold=0.8) with Haploview
4.2 software, and found that the polymorphism rs7042542
(21420T.G) was a tagSNP which representing the genetic
information of other SNPs (Figure S1). In addition, adding the
rs1571801 (97906C.A) SNP within the intron 1 of DAB2IP gene
that had been reported to be significantly associated with increased
risk of aggressive prostate cancer as two GWAS studies shown
[19], we genotyped this two SNPs (21420T.G, and 97906C.A)
in our study (Figure S2).
Genotyping analysis
Genomic DNA was extracted from 1 ml of a leukocyte cell
pellet which was obtained from the buffy coat by centrifugation of
5 mL of peripheral blood, using the DNA Blood Mini Kit
(Qiagen, Valencia, A), according to the manufacturer’s instruc-
tions. DNA purity and concentrations were determined by
measurement of spectrophotometric absorbance at 260 nm and
280 nm.
The two SNPs were genotyped using the polymerase chain
reaction-restriction fragment length polymorphism (PCR-RFLP)
method. For 21420T.G, a 132 bp PCR product was amplified
from genomic DNA using specific primers: 59-CTCCTGACCT
CAGGTGATC C-39 (forward), 59-TGGTGGGGAGGACAAA-
GATGCATCTGA-39 (reverse). PCR was performed in 25 ul
reaction systems. After initial denaturation at 94uC for 5 min,
there were 35 cycles at 94uC for 30 s, 61uC for 30 s, and 72uC for
60 s, and then a final extension step of 72uC for 7 min. The
amplified fragments were digested with MlyI (New England
BioLabs) overnight at 37uC, and the products were separated in
3.5% agarose gel. The 21420GG genotype produced 2 bands
(112 and 20 bp), whereas the 21420TT genotype produced a
single band (132 bp), and the heterozygotes displayed all 3 bands
(132, 112 and 20 bp) (Figure S1). For 97906C.A, a 98 bp PCR
product was amplified from genomic DNA using specific primers:
59-AAACAGGCATAAGG TTTTAAGT-39 (forward), 59-AAT-
TTGACTTCCAAGTTGTC-39 (reverse). Digested with Tsp5091
(New England BioLabs) overnight at 65uC, the 97906AA genotype
produced 2 bands (52 and 46 bp), 97906CC genotype produced a
single band (98 bp), and the heterozygotes displayed all 3 bands
(98, 52 and 46 bp) (Figure S2).
The results were evaluated by two experimenters independently
who were blinded to the subjects’ patient or control status. We
randomly selected 10% samples for each of the 2 SNPs to perform
repeat assays, and the results were 100% concordant. For each
target genotype of the PCR products were purified and confirmed
by direct sequencing (Figure S3).
DAB2IP mRNA expression analysis
We performed qRT-PCR to determine whether the 97906C.A
had an effect on DAB2IP gene expression in vivo. 32 tumor tissues
and their adjacent normal tissues were collected from the patients
who did not receive chemotherapy and/or radiotherapy before
underwent complete surgical resection of a primary lung cancer.
All tumor samples were histologically confirmed and genotypes of
these samples were all sequencing confirmed. Total RNA were
extracted by using Trizol Reagent (Invitrogen, Inc.). An aliquot of
total RNA (1 ug) was then reverse transcribed to complementary
DNA by using oligo primer and SuperscriptII (Invitrogen).
Relative mRNA expression levels of DAB2IP and an internal
Genetic Variants in DAB2IP and Lung Cancer Risk
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sequence detection system (Applied Biosystems) based on the
SYBR-Green method. The primers used for DAB2IP were 59-
CTG AGC GGG ATA AGT GGA TGG -39 (forward) and 59-
AAA CAT TGT CCG TCT TGA GCT T -39 (reverse) and for b-
actin were 59-GGC GGC ACC ACC ATG TAC CCT-39 and 59-
AGG GGC CGG ACT CGT CAT ACT-39. Method of 2
Dt was
used to demonstrate the level of DAB2IP gene’s expression
(Figure 2). All analyses were performed in a blinded fashion with
the laboratory persons unaware of genotyping data. Each assay
was done in triplicate.
Detection of DAB2IP/MLL fusion gene
Because von Bergh AR et al. reported that the exon 2 of
DAB2IP gene was fused with the intron 9 of the MLL gene in an
acute myeloid leukemia patient and thus lost its function, we
performed PCR to detect the possible effect of 97906C.A
polymorphism on making DAB2IP/MLL fusion gene. Genomic
DNA was extracted from 82 lung cancer tissues and their adjacent
normal tissues were collected during the surgical excision in the
first, second and tumor hospitals of Guangzhou Medical College
(Guangzhou, China) and stored in 280uC refrigerator. We
amplified the fragment of DAB2IP/MLL fusion gene with PCR
methods as von Bergh AR described [28]. The forward primer was
near exon 2 of DAB2IP gene (59- CATCTGATGCCGAGGCT-
GAA-39), and the reverse primer was in the exon 10 of MLL gene
(59-GTCCACTCTG ATCCTGTGGACT-39). The PCR prod-
ucts would be 700–900 bp length. The amplified fragments were
cloned with the TOPO TA cloning kit (Invitrogen, Carlsbad, CA)
to purify and increase the amount, and were further sequenced by
the commercial company of Invitrogen with Applied Biosystems
ABI 3730 DNA analyzer.
Statistical analysis
The chi-square tests were used to assess differences in the
distribution of sub-nation between cases and controls as well as the
allele and genotypes. The Hardy-Weinberg equilibrium (HWE)
was tested by a goodness-of-fit chi-square test to compare the
expected genotype frequencies with observed genotype frequencies
in cancer-free controls. The association between case-control
status and each SNP, measured with the odds ratio (OR) and its
corresponding 95% confidence interval [29], was estimated using
an unconditional logistic regression model, with and without
adjustment for age, sex, smoking status, alcohol use, BMI. Logistic
regression model was also used for the trend test. In the
stratification analysis, we assessed the main effect of DAB2IP in
each subgroup and the interaction among the DAB2IP polymor-
phisms and selected variables on cancer risk by fitting a
multiplicative interaction with unconditional logistic regression
model; the Multifactor Dimensionality Reduction (MDR) software
was used to validate the possible interaction [30]. The 2LD
program and the PROC ALLELE statistical procedure in SAS/
Genetics (SAS Institute Inc., Cary, NC) software were used to
detect the LD of the two SNPs. Pearson correlation analyses,
ANOVA tests and Cox regression models were used for analyzing
the age of onset in lung cancer patients by DAB2IP genotypes. All
statistical tests were 2-sided and P,0.05 was considered
statistically significant.
Supporting Information
Figure S1 The block and tagSNP in the promoter region of
DAB2IP gene.
(TIF)
Figure S2 Genomic structure, locations of SNPs in the promoter
and intron 1. The nucleotide 59 of the ATG-translation initiation
codon is 21, +1 corresponds to the A of the ATG-translation
initiation codon in the reference sequence. 21420T.G and
21274T.C were in complete LD. Thus, two SNPs (21420T.G,
97906C.A) were selected in our study. Bioinformatics analysis
shows that 97906C.A locates in the ECR region.
(TIF)
Figure S3 DAB2IP 21420T.G genotyping by direct sequenc-
ing: (a) TT genotype; (b) TG genotype; (c) GG genotype;
97906C.A genotyping by direct sequencing: (a) CC genotype;
(b) CA genotype; (c) AA genotype.
(TIF)
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